BPI Labs LLC is wholly owned by Belcher Pharmaceuticals LLC
Store at 2C to 8C after reconstitution
Khani M, Afsahi R, Nasab AE, et al
Human dose recommendations in non-peer-reviewed sources are extrapolated from animal data or empirical observations and lack pharmacokinetic or pharmacodynamic validation
Yet, when administered, Lactobacillaceae and Bifidobacteriaceae taxa that have the genetic and biochemical potential 34 might produce riboflavin in situ as a (temporary) part of the gut (and other) microbiota, resulting in altered epithelial morphology as shown in a murine in vivo model 179
Rooted in rigorous scientific research, this therapy leverages the remarkable properties of BPC-157, a synthetic peptide that holds the potential to unlock the body's innate regenerative capacities